Vipul Organics inches up as its membrane unit starts commercial sales of membranes
Vipul Organics is currently trading at Rs. 194.95, up by 0.20 points or 0.10% from its previous closing of Rs. 194.75 on the BSE.
The scrip opened at Rs. 200.05 and has touched a high and low of Rs. 206.50 and Rs. 192.20 respectively. So far 2950 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 249.00 on 09-Jul-2025 and a 52 week low of Rs. 116.00 on 09-May-2025.
Last one week high and low of the scrip stood at Rs. 213.05 and Rs. 156.80 respectively. The current market cap of the company is Rs. 369.85 crore.
The promoters holding in the company stood at 63.94%, while Institutions and Non-Institutions held 0.17% and 35.88% respectively.
Vipul Organics’ membrane unit -- AdiMem Technologies has commenced commercial sales of membranes. Transitioning from pilot to full-scale, the company will launch Reverse Osmosis (RO) and Ultrafiltration (UF) membrane manufacturing at its Sayakha, Gujarat facility, leveraging proprietary Reverse Phase Transition technology for indigenously produced, high-performance membranes. AdiMem Technologies is India's first fully indigenous manufacturer of membranes.
AdiMem now supplies membranes alongside end-to-end Effluent Treatment Plants (ETP), Sewage Treatment Plants (STP), and pre-treatment systems, for chemicals, pharma, and other sectors. The Sayakha unit of AdiMem will integrate manufacturing, rolling, quality control, and a performance testing infrastructure, enabling comprehensive water and wastewater solutions and consistent product performance at scale.
Membrane revenues are expected to impact the revenues and the margins of the company. The company is targeting 25% of its topline coming from sales of Membranes and Membrane based solutions in the next three years. The company is also targeting a sizeable part of the $6.33 billion India filtration market projected for 2033. Backed by a Rights Issue fuelling the Sayakha ramp-up, the company projects significant growth in FY2027 amid 12-15% annual chemical membrane demand growth.
